Julie S. Larsen

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Kim N., Neeraj Agarwal, Anders Bjartell et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Kim N., Simon Chowdhury, Anders Bjartell et al. · Journal of Clinical Oncology · 2021 · 508 citations · Full text

Medicine, Oncology, Pharmacology +16

Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial

David P. Steensma, Maria R. Baer, James L. Slack et al. · Journal of Clinical Oncology · 2009 · 314 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Evaluation of Conventional Press-and-Breathe Metered-Dose Inhaler Technique in 501 Patients

Julie S. Larsen, Mary Hahn, Bruce P. Ekholm et al. · Journal of Asthma · 1994 · 119 citations

Health Professions, Clinical Sciences, Respiratory Therapy +15

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

S. Chowdhury, Anders Bjartell, Neeraj Agarwal et al. · Annals of Oncology · 2023 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +17